Cargando…

Application of DNA sequences in anti-counterfeiting: Current progress and challenges

Counterfeiting has never been more challenging than during the COVID-19 pandemic as counterfeit test kits and therapeutics have been discovered in the market. Current anti-counterfeiting labels have weaknesses: they can either be duplicated easily, are expensive or ill-suited for the existing comple...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharief, Saad Asadullah, Chahal, Prem, Alocilja, Evangelyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579332/
https://www.ncbi.nlm.nih.gov/pubmed/33839229
http://dx.doi.org/10.1016/j.ijpharm.2021.120580
_version_ 1784812157761748992
author Sharief, Saad Asadullah
Chahal, Prem
Alocilja, Evangelyn
author_facet Sharief, Saad Asadullah
Chahal, Prem
Alocilja, Evangelyn
author_sort Sharief, Saad Asadullah
collection PubMed
description Counterfeiting has never been more challenging than during the COVID-19 pandemic as counterfeit test kits and therapeutics have been discovered in the market. Current anti-counterfeiting labels have weaknesses: they can either be duplicated easily, are expensive or ill-suited for the existing complex supply chains. While RFID tags provide for an excellent alternative to current anti-counterfeiting methods, they can prove to be expensive and other routes involving nanomaterials can be difficult to encrypt. A DNA based anticounterfeiting system has significant advantages such as relative ease of synthesis and vast data storage abilities, along with great potential in encryption. Although DNA is equipped with such beneficial properties, major challenges that limit its real-world anti-counterfeiting applications include protection in harsh environments, rapid inexpensive sequence determination, and its attachment to products. This review elaborates the current progress of DNA based anti-counterfeiting systems and identifies technological gaps that need to be filled for its practical application. Progress made on addressing the primary challenges associated with the use of DNA, and potential solutions are discussed.
format Online
Article
Text
id pubmed-9579332
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-95793322022-10-19 Application of DNA sequences in anti-counterfeiting: Current progress and challenges Sharief, Saad Asadullah Chahal, Prem Alocilja, Evangelyn Int J Pharm Article Counterfeiting has never been more challenging than during the COVID-19 pandemic as counterfeit test kits and therapeutics have been discovered in the market. Current anti-counterfeiting labels have weaknesses: they can either be duplicated easily, are expensive or ill-suited for the existing complex supply chains. While RFID tags provide for an excellent alternative to current anti-counterfeiting methods, they can prove to be expensive and other routes involving nanomaterials can be difficult to encrypt. A DNA based anticounterfeiting system has significant advantages such as relative ease of synthesis and vast data storage abilities, along with great potential in encryption. Although DNA is equipped with such beneficial properties, major challenges that limit its real-world anti-counterfeiting applications include protection in harsh environments, rapid inexpensive sequence determination, and its attachment to products. This review elaborates the current progress of DNA based anti-counterfeiting systems and identifies technological gaps that need to be filled for its practical application. Progress made on addressing the primary challenges associated with the use of DNA, and potential solutions are discussed. Elsevier B.V. 2021-06-01 2021-04-09 /pmc/articles/PMC9579332/ /pubmed/33839229 http://dx.doi.org/10.1016/j.ijpharm.2021.120580 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Sharief, Saad Asadullah
Chahal, Prem
Alocilja, Evangelyn
Application of DNA sequences in anti-counterfeiting: Current progress and challenges
title Application of DNA sequences in anti-counterfeiting: Current progress and challenges
title_full Application of DNA sequences in anti-counterfeiting: Current progress and challenges
title_fullStr Application of DNA sequences in anti-counterfeiting: Current progress and challenges
title_full_unstemmed Application of DNA sequences in anti-counterfeiting: Current progress and challenges
title_short Application of DNA sequences in anti-counterfeiting: Current progress and challenges
title_sort application of dna sequences in anti-counterfeiting: current progress and challenges
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579332/
https://www.ncbi.nlm.nih.gov/pubmed/33839229
http://dx.doi.org/10.1016/j.ijpharm.2021.120580
work_keys_str_mv AT shariefsaadasadullah applicationofdnasequencesinanticounterfeitingcurrentprogressandchallenges
AT chahalprem applicationofdnasequencesinanticounterfeitingcurrentprogressandchallenges
AT alociljaevangelyn applicationofdnasequencesinanticounterfeitingcurrentprogressandchallenges